Company Profiles

driven by the PitchBook Platform

AbCellera

AbCellera
2012 FOUNDED
PRIVATE STATUS
11-50 EMPLOYEES
Later Stage VC LATEST DEAL TYPE
$818K LATEST DEAL AMOUNT
4 INVESTORS
Description

Developer monoclonal antibodies designed to help biotechnology and pharmaceutical partners to accelerate the discovery and development of next-generation monoclonal antibody therapies. The company's microfluidic single-cell platform screens millions of immune cells in a single day, increasing the speed and efficiency of monoclonal antibody discovery from natural immune responses of immunized animals and human patients delivering new avenues for human immune profiling and infectious disease research, with the potential to accelerate the development of urgently needed diagnostic tests and vaccines.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Primary Office
2125 East Mall
Suite 305
Vancouver, British Columbia V6T 1Z4
Canada

+1 (604) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore AbCellera’s full profile, request a free trial.

AbCellera Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 04-Apr-2017 $818K 00000 Completed Generating Revenue
4. Grant 19-Jan-2017 Completed Generating Revenue
3. Grant 26-Jun-2015 00000 Completed Startup
2. Seed Round 09-Aug-2014 Completed Startup
1. Grant 27-Sep-2013 $62K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

AbCellera Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Bill & Melinda Gates Foundation Not-For-Profit Venture Capital 000 0000 000000 0
Western Economic Diversification Canada Government 000 0000 000000 0
NorthView Lifesciences Venture Capital Minority 000 0000 000000 0
New Ventures BC Accelerator/Incubator 000 0000 000000 0

AbCellera Executive Team (5)

Name Title Board
Seat
Contact
Info
Carl Hansen Ph.D Co-Founder, President, Chief Executive Officer & Board Member
Kathleen Lisaingo Ph.D Co-Founder
Kevin Heyries Ph.D Co-Founder
Veronique Lecault Co-Founder
Daniel Da Costa Co-Founder & Engineer

AbCellera Board Members (4)

Name Representing Role Since Contact
Info
Andrew Booth Self Board Member 000 0000
Carl Hansen Ph.D AbCellera Co-Founder, President, Chief Executive Officer & Board Member 000 0000
Douglas Janzen NorthView Lifesciences Chairman 000 0000

1 Former Board Member

You’re viewing 3 of 4 board members. Get the full list »
Questions or concerns about this profile? Reach out to website-support@pitchbook.com